Is pyrukynd for pk deficiency?

Is Pyrukynd (mitapivat) used for pyruvate kinase (PK) deficiency?

Yes. Pyrukynd (mitapivat) is a treatment for hemolytic anemia due to pyruvate kinase (PK) deficiency.

What PK deficiency condition does Pyrukynd treat?

Pyrukynd is used in patients with PK deficiency that causes chronic hemolysis, meaning patients typically have anemia from red blood cell breakdown.

Is Pyrukynd approved for PK deficiency specifically, or for other diseases?

It is specifically indicated for PK deficiency–related hemolytic anemia (not for unrelated forms of anemia).

Where can I check the latest indication/patent details?

For up-to-date labeling and related business/patent information, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/

Sources

1. https://www.drugpatentwatch.com/